Skip to content

Clinical trials

Lymphoproliferative Disorders trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoproliferative Disorders Phase: Not applicable Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20061
20072
20081
20091
20101
20121
20161
20171
20191
20211
20223
20231
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Completed5
Unknown status4
Terminated3
Not yet recruiting2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Azienda Ospedaliero-Universitaria di Parma2
Fairview University Medical Center2
Antalya City Hospital1
City of Hope Medical Center1
Daniel Chernavvsky, MD, CRC1
European Institute of Oncology1
Hospices Civils de Lyon1
I.M. Sechenov First Moscow State Medical University1
M.D. Anderson Cancer Center1
Masonic Cancer Center, University of Minnesota1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoproliferative Disorders21
Multiple Myeloma9
Lymphoma8
Myeloproliferative Disorders7
Leukemia5
Lymphoma, B-Cell, Marginal Zone5
Lymphoma, Follicular5
Lymphoma, Non-Hodgkin5
Lymphoma, T-Cell, Cutaneous5
Precursor Cell Lymphoblastic Leukemia-Lymphoma5

Trials

Showing 76 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.